24,25,26-trihydroxyvitamin D3/24,25,26-trihydroxycholecalciferol

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 24,25,26-trihydroxyvitamin D3/24,25,26-trihydroxycholecalciferol
• 英文别名: (6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-1,2,3-triol
• 化学式: C₂₇H₄₄O₄
• 分子量: 432.6
• InChiKey: KUIHAHXZFFZCMZ-QJCCVWJUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  31
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  80.9
• 氢给体数：
  4
• 氢受体数：
  4

文献信息

• METHODS AND ASSAYS FOR USE IN DIAGNOSIS OF LAMINITIS
  申请人：Pepsis Limited

  公开号：EP3773919A1

  公开（公告）日：2021-02-17
• JPS58210018A
  申请人：——

  公开号：JPS58210018A

  公开（公告）日：1983-12-07
• [EN] METHODS AND ASSAYS FOR USE IN DIAGNOSIS OF LAMINITIS<br/>[FR] PROCÉDÉS ET DOSAGES POUR UTILISATION DANS LE DIAGNOSTIC DE LA FOURBURE AIGUË
  申请人：PEPSIS LTD

  公开号：WO2019186141A1

  公开（公告）日：2019-10-03

  The invention concerns a method and assay for qualifying equine laminitis disease status in a subject by measuring specific biomarkers, comparing the level of said biomarker to a control level; and correlating the measurement with laminitis disease status, wherein a statistically relevant elevated level of said biomarker is present in said sample relative to said control level.The invention further relates to immuno-based methods and assays for detecting toxins relevant to laminitis and to the use of antibodies for assay and diagnostic purposes.